West Pharmaceutical Services (NYSE: WST) surged 22.7% in pre-market trading on July 24, 2025, reaching $279.00 after closing at $227.31 the previous day.
Trading volume spiked following the company’s strong Q2 2025 results: adjusted EPS of $1.84 beat estimates by 21.9% and revenue of $766.5 million topped expectations by 5.5%. Both full-year earnings and revenue guidance were raised above consensus, fueling the sharp move higher.